|
PALI | Palisade Bio, Inc. |
|
|
PALI | Palisade Bio, Inc. |
| Biological Products (no Diagnostic Substances) |
| Book value per $ invested | $ 0.18 |
| Leverage | 53.94% |
| Market Cap | $ 17.4m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -11.2m |
| Margin | -4624.26% |
Leading BioSciences, Inc. develops therapies to improve human health through therapeutic protection of the gastrointestinal mucosal barrier. The company is headquartered in Carlsbad, California.